Lantern Pharma Inc (NAS:LTRN)
$ 3.74 -0.15 (-3.86%) Market Cap: 40.34 Mil Enterprise Value: 14.19 Mil PE Ratio: 0 PB Ratio: 1.51 GF Score: 39/100

Lantern Pharma Inc Annual Shareholders Meeting Transcript

Jun 16, 2023 / 03:00PM GMT
Release Date Price: $6.01 (+1.69%)
Panna Sharma
Lantern Pharma Inc. - CEO, President, & Director

Good morning, everyone, and welcome to Lantern Pharma's 2023 annual meeting of stockholders. My name is Panna Sharma, and I'm President and CEO of Lantern Pharma. I'll be presiding at the meeting today. It is now 11 o'clock, and thank you for attending.

Also in attendance at the meeting today are members of our Board of Directors; Michele Epstein of EisnerAmper LLP, the company's external auditor; and David Margrave, Chief Financial Officer and Secretary of Lantern Pharma will also be acting as the Secretary and Inspector of Elections of this meeting.

Now let me give you an outline of the plan for this meeting. As described in the notice and proxy statement previously distributed, you are entitled to participate in and vote at this meeting if you are a stockholder of record as of the close of business on April 21, 2023, which is the record date for this meeting or hold a legal proxy for the meeting provided by your bank, broker, or nominee.

If you have a voting control number and wish to vote during this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot